| Literature DB >> 27195266 |
Primali Rukmal Jayasooriya1, Lindumini Nayanahari Madawalagamage1, Balapuwaduge Ranjit Rigorbert Nihal Mendis2, Tommaso Lombardi2.
Abstract
In the head and neck region, synovial sarcomas (SS) are rare tumours. We describe the diagnostic approach to SS based on two cases which developed in a 26-year-old male in the face and in a 53-year-old female on the alveolar mucosa of the upper jaw. The demographic profile of the patients was compatible with the literature. Histopathologically, both tumours presented as unencapsulated spindle cell tumours arranged into short fascicles. Although the chromosomal translocation of t(X;18)(p11.2;q11.2), transducin-like enhancer of split 1 (TLE-1) and SMARCB1 antibodies derived from gene expression studies are considered as the most sensitive makers to diagnose SS, these facilities were not available. Therefore, our cases were diagnosed as monophasic fibrous SS, utilizing a panel of immunohistochemical markers, including cytokeratins, EMA, Bcl-2, and CD99 as positive indicators and CD34, SMA, MYO-D, and S-100 as negative indicators. PAS staining was used to identify glycogen and to exclude spindle cell carcinomas and leiomyosarcoma, while Alcian blue was used to identify myxoid ground substance and to exclude nodular fasciitis. In conclusion, SS, although rare, should be included in the differential diagnosis of spindle cell tumours of the face and oral mucosa.Entities:
Keywords: Diagnosis; Head and neck; Oral cavity; Oral mucosa; Synovial sarcoma
Year: 2016 PMID: 27195266 PMCID: PMC4868929 DOI: 10.1159/000444876
Source DB: PubMed Journal: Dermatopathology (Basel) ISSN: 2296-3529
Fig. 1Extraoral presentation of the lesion (case 1).
Fig. 2A tumour composed of spindle cells showing a fascicular arrangement (case 1). HE. ×20.
Fig. 3Focal EMA positivity in the tumour (case 1). ×20.
Fig. 4Intraoral presentation of the lesion (case 2).
Fig. 5A tumour composed of spindle cells arranged into fascicles (case 2). ×10.
Fig. 6Note the undifferentiated cell component present close to the non-dysplastic surface epithelium (case 2). ×20.
Fig. 7CK19 positivity in the undifferentiated cell component (case 2). ×20.
Fig. 8MIB-1 activity of the tumour cell component (case 2). ×10.
Literature review-based comparison of demographic features of SS of the head and neck with the present cases
| Feature | Literature review-based findings [ | Present cases (n = 2) |
|---|---|---|
| Age distribution | ||
| Mean age, years | 28.6 | 38 |
| Age range, years | 17–86 | 26–53 |
| Gender distribution | ||
| Male | 45 | 1 |
| Female | 24 | 1 |
| Male:female ratio | 1.9:1 | 1:1 |
| Site distribution | ||
| Head | 22 | 2 |
| Neck | 31 | 0 |
| Unknown | 16 | 0 |
| Histopathological subtype | ||
| Biphasic | 19 | 0 |
| Monophasic | 29 | 2 |
| Poorly differentiated | 06 | 0 |
| Unspecified | 15 | 0 |
| Prognosis | ||
| 5-year survival | 58–100% | unknown |
Clinicopathological comparison of SS and SpCC with the present cases
| Feature | SpCC [ | SS [ | Case 1 | Case 2 |
|---|---|---|---|---|
| Habits | Betel chewing, smoking, alcohol use for oral lesions, radiotherapy | Unknown | Occasional smoker | No history of relevant habits |
| Age | 5th–6th decade | Predominantly in young adults, 90% occur before 60 years of age | Young adult | 6th decade |
| Gender | Male predilection (M:F 3:1) | Slight male predilection | Male | Female |
| Squamoid differentiation | Present in 50–80% of tumours | Absent in monophasic SS | Absent | Absent |
| Polypoid configuration | Present in 90% of tumours | Absent | Absent | Absent |
| Surface epithelial dysplasia | Present | Absent | Absent | Absent |
| Tumour giant cells | Present | Absent | Absent | Absent |
| Collagenous stroma | Present | Minimal stroma in monophasic SS | Absent | Absent |
| High degree of anaplasia | Present in 70–90% of tumours | Absent | Absent | Absent |
| Pan-cytokeratin | Diffuse positivity in 50–70% of tumours | Focal positive in monophasic SS | Negative | Focal positive |
| CK7/19 | Negative | Positive | Negative | Focal positive |
| CK8/18 | Positive | Negative | Unavailable | Unavailable |
| EMA | Positive in 17–29% of tumours | Positive in 90% of tumours | Focal positive | Focal positive |
| Bcl2 | Data unavailable | Positive in 98% of tumours | Negative | Positive |
| CD99 | Data unavailable | Positive in 60% of tumours | Negative | Positive |
| TLE1 | Data unavailable | Positive in 100–80% of tumours | Unavailable | Unavailable |
| P63 | Positive in 30% of tumours | Negative | Unavailable | Unavailable |
| Calponin | Positive in 100% of tumours | Focal positive in 30% of tumours | Unavailable | Unavailable |
| Smooth muscle actin | Positive in 16–30% of tumours | Negative | Negative | Negative |
| S-100 | Positive in 5–7% of tumours | Positive in 40% of tumours | Negative | Negative |
| Demin | Positive in 3–18% of tumours | Negative | Negative | Negative |
| SMARCB1 | Data unavailable | Reduced expression in 92% of tumours | Unavailable | Unavailable |
| PAS stain | Positive due to presence of glycogen | Negative | Negative | Negative |
| Reticulin stain | Positivity present around cell clusters | Positivity present around individual cells | Positive around individual cells | Positive around individual cells |
| FISH | Data unavailable | T(X:18) translocation | Not done | Not done |